Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

iBio, Inc. Director's Dealing 2010

Dec 3, 2010

35045_dirs_2010-12-03_20dcb482-87fd-428f-aa32-76e2af8e1349.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: iBio, Inc. (IBPM)
CIK: 0001420720
Period of Report: 2010-10-29

Reporting Person: Elliott Arthur Y (Director)

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
Stock Option (right to buy) $2.18 2020-10-29 Common Stock (60000) Direct

Footnotes

F1: The option vests in three equal annual installments, beginning on October 29, 2011.